For Research Use Only. Selank is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
Tuftsin and the Immune Connection
Tuftsin is a naturally occurring tetrapeptide with immunomodulatory activity that was identified in the 1970s. The native peptide is derived from proteolytic cleavage of the heavy chain of immunoglobulin G and has documented effects on macrophage function, phagocytosis, and natural killer cell activity. The short half life of native tuftsin limited its research utility, which motivated the development of stable synthetic analogs including Selank.
Selank retains the core tuftsin sequence with additional residues that extend stability while preserving some of the immunomodulatory activity. The retained immunomodulatory effects are one of the features that distinguishes Selank from the Semax peptide covered in the adjacent cluster, and the comparative pharmacology is discussed in the Selank versus Semax comparison article in this cluster.
The Nature subject hub on tuftsin archives primary research on the parent peptide biology, and the ScienceDirect tuftsin topic page provides additional entry points into the literature.
Cytokine Expression Research
Published Selank research has documented effects on cytokine expression patterns in rodent models and in cultured immune cell systems. The findings include shifts in the Th1 to Th2 balance toward Th2 predominance, reductions in pro inflammatory cytokine production including tumor necrosis factor and interleukin 6, and increases in anti inflammatory cytokine production including interleukin 10. The pattern is consistent with general immunomodulatory activity that shifts immune tone toward less inflammatory profiles.
The specific cytokine profile shifts have been examined across multiple research contexts including stress paradigms, inflammatory challenge paradigms, and baseline measurements in healthy animals. The findings are reproducible across contexts and across laboratories, which supports the interpretation that the effects reflect consistent underlying biology rather than context specific responses.
The mechanism of cytokine modulation involves both direct effects on immune cells and indirect effects through central nervous system modulation of autonomic and neuroendocrine outputs that influence immune function. The Cell Press journal Cell Reports Medicine and the Frontiers in Immunology open access journal both archive primary research on neuroimmune interactions that provides useful context.
Stress Induced Immune Changes
One of the research areas where Selank immunomodulation has been examined in detail is in stress induced immune changes. Stress activates the HPA axis and sympathetic nervous system with consequent effects on immune function including reduced lymphocyte counts, shifted cytokine profiles, and impaired antibody responses to challenge. Research on Selank in stress paradigms documents attenuation of these stress induced immune changes alongside the anxiolytic effects that are the peptide's core behavioral pharmacology covered in the GABAergic research article.
The integrated stress and immune effects of Selank are consistent with the peptide's broader profile as a modulator of the organism's response to challenge. The combined behavioral and immune effects in stress paradigms make Selank a research tool for studies that want to examine the interaction between stress response and immune function in rodent models.
The Wiley Online Library psychoneuroimmunology collection archives primary research on stress immune interactions that is useful context for the Selank research.
Antiviral Research Applications
The immunomodulatory effects of Selank have motivated research on antiviral applications in rodent viral infection models. Published research documents effects on viral clearance and on infection associated symptoms in several viral challenge models. The mechanism is not a direct antiviral effect on viral replication but rather an indirect effect through enhanced host immune response to the infection.
The research on viral infection models connects to the broader Russian research program on Selank as a nonspecific resistance enhancing compound. The biology is related to the broad concept of adjuvant immunomodulation that has been applied to various research contexts including infection, vaccination response, and immune challenge models.
Macrophage and Dendritic Cell Effects
Selank effects on macrophages have been examined with findings consistent with tuftsin related activity. Published research documents enhanced phagocytic activity in treated macrophages, shifts in macrophage polarization profiles, and modulation of the inflammatory cytokine production patterns. Dendritic cell research has documented effects on antigen presentation and on the overall maturation profile of dendritic cells exposed to the peptide.
These cellular level findings integrate with the cytokine expression findings to produce a coherent picture of Selank immunomodulation. The compound affects innate immune cells to shift their functional profile, which in turn affects the downstream adaptive immune responses that develop in the context of the altered innate signaling.